Evidence map›Paper›PMID 33143339›Full record

ArticleMicromachines2020

A Microfluidic Chip Architecture Enabling a Hypoxic Microenvironment and Nitric Oxide Delivery in Cell Culture.

Samineh Barmaki, Daniela Obermaier, Esko Kankuri, Jyrki Vuola, Sami Franssila, Ville Jokinen

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Application of microfluidic chips in anticancer drug screening.Bosnian journal of basic medical sciences · 2022
    Review
  5. Frontiers in medicine · 2022
    Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Samineh BarmakiDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.ORCID 0000-0003-1831-1889
Daniela ObermaierPreSens Precision Sensing GmbH, 93053 Regensburg, Germany.
Esko KankuriDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland.ORCID 0000-0002-2193-8773
Jyrki VuolaHelsinki Burn Centre, Jorvi Hospital, Helsinki University Hospital and University of Helsinki, 00260 Helsinki, Finland.ORCID 0000-0003-1692-2344
Sami FranssilaDepartment of Chemistry and Materials Science, School of Chemical Engineering, Aalto University, 00076 Espoo, Finland.
Ville JokinenDepartment of Chemistry and Materials Science, School of Chemical Engineering, Aalto University, 00076 Espoo, Finland.
University of Helsinki · FIAalto University · FIPreSens Precision Sensing (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hypoxic (low oxygen level) microenvironment and nitric oxide paracrine signaling play important roles in the control of both biological and pathological cell responses. In this study, we present a microfluidic chip architecture for nitric oxide delivery under a hypoxic microenvironment in human embryonic kidney cells (HEK-293). The chip utilizes two separate, but interdigitated microfluidic channels. The hypoxic microenvironment was created by sodium sulfite as the oxygen scavenger in one of the channels. The nitric oxide microenvironment was created by sodium nitroprusside as the light-activated nitric oxide donor in the other channel. The solutions are separated from the cell culture by a 30 µm thick gas-permeable, but liquid-impermeable polydimethylsiloxane membrane. We show that the architecture is preliminarily feasible to define the gaseous microenvironment of a cell culture in the 100 µm and 1 mm length scales.

Indexed as

cell culturegasotransmitterhypoxiamicroenvironmentmicrofluidic chipnitric oxideoxygen depletionsodium nitroprusside

Identifiers

PMID33143339
PMCPMC7692389
OpenAlexW3096053579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.